Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -40.09% is 28% below its 5-year average of -31.34%, near the low end of its 5-year range (-55.25%–47.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 107.56% below its 12-month average of -19.31%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.09%.
RETURN ON EQUITY (ROE)
-40.09%
RETURN ON EQUITY (ROE) AVG TTM
-19.31%
RETURN ON EQUITY (ROE) AVG 3Y
-12.20%
RETURN ON EQUITY (ROE) AVG 5Y
-31.34%
RETURN ON EQUITY (ROE) AVG 10Y
-46.88%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-107.56%
CURRENT VS 3Y AVG
-228.60%
CURRENT VS 5Y AVG
-27.90%
CURRENT VS 10Y AVG
+14.50%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.55%
median of 589 covered companies
CURRENT VS SECTOR MEDIAN
-1.35%
vs the sector median at left
Agios Pharmaceuticals, Inc.
Market Cap
$1.90B
Return on Equity (ROE)
-40.09%
TTM Avg
-19.31%
3Y Avg
-12.20%
5Y Avg
-31.34%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$1.88B
Return on Equity (ROE)
N/A
TTM Avg
-157.29%
3Y Avg
-33.70%
5Y Avg
49.06%
Market Cap
$1.87B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
Market Cap
$1.95B
Return on Equity (ROE)
-179.99%
TTM Avg
-188.10%
3Y Avg
28.98%
5Y Avg
-2.67%
Market Cap
$1.96B
Return on Equity (ROE)
-13.09%
TTM Avg
-10.89%
3Y Avg
-18.29%
5Y Avg
-19.41%
Market Cap
$1.84B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.97B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$1.84B
Return on Equity (ROE)
4.88%
TTM Avg
4.47%
3Y Avg
6.79%
5Y Avg
5.89%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.90B | -40.09% | -19.31% | -12.20% | -31.34% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Novavax, Inc. (NVAX)vs › | $1.88B | N/A | -157.29% | -33.70% | 49.06% |
| Azenta, Inc. (AZTA)vs › | $1.87B | -8.14% | -6.28% | -6.47% | -2.03% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -179.99% | -188.10% | 28.98% | -2.67% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -13.09% | -10.89% | -18.29% | -19.41% |
| Absci Corporation (ABSI)vs › | $1.84B | -49.19% | -59.18% | -54.84% | -44.72% |
| Immunome, Inc. (IMNM)vs › | $1.97B | -48.43% | -97.59% | -126.46% | -100.04% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 4.88% | 4.47% | 6.79% | 5.89% |
| Novocure Ltd (NVCR)vs › | $1.83B | -43.94% | -43.41% | -41.23% | -29.16% |
ROE
-40.1%
ROA
-37.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -40.09% |
| 2026-03-31 | -38.10% |
| 2025-12-31 | -34.60% |
| 2025-09-30 | -31.24% |
| 2025-06-30 | 47.47% |
| 2025-03-31 | 45.41% |
| 2024-12-31 | 43.72% |
| 2024-09-30 | 41.45% |
| 2024-06-30 | -55.25% |
| 2024-03-31 | -47.40% |
| 2023-12-31 | -43.41% |
| 2023-09-30 | -24.76% |
| 2023-06-30 | -21.78% |
| 2023-03-31 | -21.04% |
| 2022-12-31 | -21.06% |
| 2022-09-30 | -34.56% |
| 2022-06-30 | -32.86% |
| 2022-03-31 | -29.89% |
| 2021-12-31 | -29.75% |
| 2021-09-30 | -27.78% |
| 2021-06-30 | -23.13% |
| 2021-03-31 | -17.65% |
| 2020-12-31 | -81.94% |
| 2020-09-30 | -69.11% |
| 2020-06-30 | -60.75% |
| 2020-03-31 | -57.36% |
| 2019-12-31 | -64.24% |
| 2019-09-30 | -89.43% |
| 2019-06-30 | -73.10% |
| 2019-03-31 | -56.15% |
| 2018-12-31 | -50.33% |
| 2018-09-30 | -45.06% |
| 2018-06-30 | -39.48% |
| 2018-03-31 | -39.20% |
| 2017-12-31 | -83.80% |
| 2017-09-30 | -62.89% |
| 2017-06-30 | -52.76% |
| 2017-03-31 | -78.55% |
| 2016-12-31 | -55.35% |
| 2016-09-30 | -45.49% |
| 2016-06-30 | -55.36% |
| 2016-03-31 | -40.91% |
| 2015-12-31 | -34.11% |
| 2015-09-30 | -27.62% |
| 2015-06-30 | -14.80% |
| 2015-03-31 | -10.83% |
| 2014-12-31 | -12.61% |
| 2014-09-30 | -18.88% |
| 2014-06-30 | -26.98% |
| 2014-03-31 | -36.61% |
| 2013-12-31 | -29.97% |
| 2013-09-30 | -22.68% |
| 2013-06-30 | -89.38% |
| 2013-03-31 | -61.15% |
| 2012-12-31 | -45.79% |
